Literature DB >> 30097391

Refining treatment choices for ADHD.

Anne Arnett1, Mark Stein2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30097391      PMCID： PMC7876993          DOI： 10.1016/S2215-0366(18)30295-5

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  10 in total

1.  Symptoms versus impairment: the case for respecting DSM-IV's Criterion D.

Authors:  Michael Gordon; Kevin Antshel; Stephen Faraone; Russell Barkley; Larry Lewandowski; James J Hudziak; Joseph Biederman; Charles Cunningham
Journal:  J Atten Disord       Date:  2006-02       Impact factor: 3.256

2.  Beyond rising rates: personalized medicine and public health approaches to the diagnosis and treatment of attention-deficit/hyperactivity disorder.

Authors:  John T Walkup; Lauren Stossel; Rebecca Rendleman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-11-22       Impact factor: 8.829

Review 3.  Recent Trends in Stimulant Usage.

Authors:  Daniel J Safer
Journal:  J Atten Disord       Date:  2015-10-20       Impact factor: 3.256

4.  Check and Double Check - the Cochrane review by Storebo et al. (2015) is indeed flawed.

Authors:  M Romanos; D Coghill; M Gerlach; K Becker; M Holtmann; M Döpfner; T Banaschewski
Journal:  Z Kinder Jugendpsychiatr Psychother       Date:  2016-09

5.  Reasons Why Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Stop and Restart Taking Medicine.

Authors:  William B Brinkman; John O Simon; Jeffery N Epstein
Journal:  Acad Pediatr       Date:  2017-09-12       Impact factor: 3.107

6.  Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts.

Authors:  Mark A Stein; Irwin D Waldman; Elizabeth Charney; Subhash Aryal; Craig Sable; Reut Gruber; Jeffrey H Newcorn
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-12-02       Impact factor: 2.576

Review 7.  Targeting Functional Impairments in the Treatment of Children and Adolescents with ADHD.

Authors:  Tyler Sasser; Erin N Schoenfelder; Mark A Stein
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

8.  Treatment Sequencing for Childhood ADHD: A Multiple-Randomization Study of Adaptive Medication and Behavioral Interventions.

Authors:  William E Pelham; Gregory A Fabiano; James G Waxmonsky; Andrew R Greiner; Elizabeth M Gnagy; William E Pelham; Stefany Coxe; Jessica Verley; Ira Bhatia; Katie Hart; Kathryn Karch; Evelien Konijnendijk; Katy Tresco; Inbal Nahum-Shani; Susan A Murphy
Journal:  J Clin Child Adolesc Psychol       Date:  2016-02-16

9.  Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.

Authors:  Samuele Cortese; Nicoletta Adamo; Cinzia Del Giovane; Christina Mohr-Jensen; Adrian J Hayes; Sara Carucci; Lauren Z Atkinson; Luca Tessari; Tobias Banaschewski; David Coghill; Chris Hollis; Emily Simonoff; Alessandro Zuddas; Corrado Barbui; Marianna Purgato; Hans-Christoph Steinhausen; Farhad Shokraneh; Jun Xia; Andrea Cipriani
Journal:  Lancet Psychiatry       Date:  2018-08-07       Impact factor: 27.083

Review 10.  Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.

Authors:  Ole Jakob Storebø; Helle B Krogh; Erica Ramstad; Carlos R Moreira-Maia; Mathilde Holmskov; Maria Skoog; Trine Danvad Nilausen; Frederik L Magnusson; Morris Zwi; Donna Gillies; Susanne Rosendal; Camilla Groth; Kirsten Buch Rasmussen; Dorothy Gauci; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  BMJ       Date:  2015-11-25
  10 in total
  4 in total

1.  Precision Medicine Care in ADHD: The Case for Neural Excitation and Inhibition.

Authors:  Ping C Mamiya; Anne B Arnett; Mark A Stein
Journal:  Brain Sci       Date:  2021-01-13

Review 2.  Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review.

Authors:  Rafał R Jaeschke; Ewelina Sujkowska; Magdalena Sowa-Kućma
Journal:  Psychopharmacology (Berl)       Date:  2021-08-26       Impact factor: 4.530

3.  A framework for characterizing heterogeneity in neurodevelopmental data using latent profile analysis in a sample of children with ADHD.

Authors:  Anne B Arnett; Brian P Flaherty
Journal:  J Neurodev Disord       Date:  2022-08-03       Impact factor: 4.074

4.  Five-year outcomes of ADHD diagnosed in adulthood.

Authors:  Elin Nylander; Orestis Floros; Timea Sparding; Eleonore Rydén; Stefan Hansen; Mikael Landén
Journal:  Scand J Psychol       Date:  2020-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.